This successful and unique two-day conference provided an opportunity for over 1,200 clinicians and researchers to examine cutting edge approaches for treating and preventing drug abuse and addiction. These science advances ranged from the latest findings on the role of genetics, experimental vaccines, the Blending Team products addressing motivational interviewing buprenorphine, and motivational incentives — and recent findings on the impact of regular exercise — all aimed at helping prevent former drug users from relapsing.

Attendees expressed excitement and gratitude about experiencing NIDA's Blending Conference and learning about the importance of research and how it is used to impact clinical outcomes.

For a detailed agenda and related presentations, please click here.